[BGLC] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -80.90%
YoY- -94.99%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 2,840 2,575 2,485 3,029 3,245 3,576 3,092 -5.49%
PBT -127 -67 -140 31 197 370 137 -
Tax 30 10 -2 14 108 75 108 -57.32%
NP -157 -77 -139 17 89 295 28 -
Tax Rate - - - -45.59% -54.72% -20.29% -79.30% -
Total Cost 2,997 2,652 2,624 3,012 3,156 3,281 3,064 -1.45%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -5.53 -3.01 -5.58 0.56 2.75 8.26 0.91 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.01 -0.01 -0.01 0.00 0.01 0.02 0.00 -
EPS Diluted -0.01 -0.01 -0.01 0.00 0.01 0.02 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.